SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Price EJ, Venables PJ. Dry eyes and mouth syndrome: a subgroup of patients presenting with sicca symptoms. Rheumatology (Oxford) 2002; 41: 41622.
  • 2
    Mariette X, Caudmont C, Berge E, Desmoulins F, Pinabel F. Dry eyes and mouth syndrome or sicca, asthenia and polyalgia syndrome? [letter] Rheumatology (Oxford) 2003; 42: 9145.
  • 3
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33: 16072.
  • 4
    Gilboe IM, Kvien TK, Husby G. Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls. J Rheumatol 1999; 26: 1694700.
  • 5
    Strombeck B, Ekdahl C, Manthorpe R, Wikstrom I, Jacobsson L. Health-related quality of life in primary Sjogren's syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 2000; 29: 208.
  • 6
    Sutcliffe N, Stoll T, Pyke S, Isenberg DA. Functional disability and end organ damage in patients with systemic lupus erythematosus (SLE), SLE and Sjögren's syndrome (SS), and primary SS. J Rheumatol 1998; 25: 638.
  • 7
    Tensing EK, Solovieva SA, Tervahartiala T, Nordstrom DC, Laine M, Niissalo S, et al. Fatigue and health profile in sicca syndrome of Sjögren's and non-Sjögren's syndrome origin. Clin Exp Rheumatol 2001; 19: 3136.
  • 8
    Tensing EK, Nordstrom DC, Solovieva S, Schauman KO, Sippo-Tujunen I, Helve T, et al. Salivary gland scintigraphy in Sjögren's syndrome and patients with sicca symptoms but without Sjögren's syndrome: the psychological profiles and predictors for salivary gland dysfunction. Ann Rheum Dis 2003; 62: 9648.
  • 9
    Derogatis L. The SCL-90-R manual-II: administration, scoring and procedures. Baltimore: Clinical Psychometric Research; 1983.
  • 10
    Parker JC, Buckelew SP, Smarr KL, Buescher KL, Beck NC, Frank RG, et al. Psychological screening in rheumatoid arthritis. J Rheumatol 1990; 17: 101621.
  • 11
    Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, Abu-Shakrah M, et al. Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol 1999; 94: 35416.
    Direct Link:
  • 12
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjogren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 5548.
  • 13
    Leplege A, Ecosse E, Verdier A, Perneger TV. The French SF-36 Health Survey: translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 1998; 51: 101323.
  • 14
    Leplege A, Ecosse E, Pouchot J, Coste J, Perneger T. Le questionnaire MOS SF-36: manuel de l'utilisateur et guide d'interprétation des scores. Paris: ESTEM; 2001.
  • 15
    Perneger TV, Leplege A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults. J Clin Epidemiol 1995; 48: 105160.
  • 16
    Guelfi JD, Pellet J. La symptom checklist: SCL-90-R: l'évaluation clinique standardisée en psychiatrie. Paris Editions Médicales Pierre Fabre 1996; 1: 7786.
  • 17
    Pariente P, Guelfi JD. Version francaise de la SCL-90-R: inventaire d'auto-évaluation psychopathologique chez les adultes. Première partie: inventaires multidimensionnelles. Psychiatr Psychobiol 1990; 5: 4963.
  • 18
    Tatu P, Pellet J, Lang F, Pichon M, Coerchon C. SCL 90 R in a sample of French-speaking subjects free of psychiatric disorders. Ann Med Psychol (Paris) 1994; 152: 18790. In French.
  • 19
    Thomas E, Hay EM, Hajeer A, Silman AJ. Sjögren's syndrome: a community-based study of prevalence and impact. Br J Rheumatol 1998; 37: 106976.
  • 20
    Bowman SJ, Booth DA, Platts RG, and the UK Sjögren's Interest Group. Measurement of fatigue and discomfort in primary Sjögren's syndrome using a new questionnaire tool. Rheumatology (Oxford) 2004; 43: 75864.
  • 21
    Drosos AA, Angelopoulos NV, Liakos A, Moutsopoulos HM. Personality structure disturbances and psychiatric manifestations in primary Sjögren's syndrome. J Autoimmun 1989; 2: 48993.
  • 22
    Strombeck B, Ekdahl C, Manthorpe R, Jacobsson LT. Physical capacity in women with primary Sjögren's syndrome: a controlled study. Arthritis Rheum 2003; 49: 6818.
  • 23
    Valtysdottir ST, Gudbjornsson B, Hallgren R, Hetta J. Psychological well-being in patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2000; 18: 597600.
  • 24
    Le Pape A, Lecompte T. Prévalence et prise en charge médicale de la dépression: France 1996–1997. Paris: Centre de recherche d'étude et de documentation en économie de la santé (Credes); 1999. p. 108.
  • 25
    Lovell A. Etude sur la surveillance dans le champ de la santé mentale. Rapport final. InVS, Octobre 2004, p.25. URL: http://www.invs.sante.fr/publications/2005/sante_mentale_110105/etude_santementale.pdf.
  • 26
    Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 27
    Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 228691.
  • 28
    Bowman SJ, Booth DA, Platts RG, Field A, Rostron J, and the UK Sjogren's Interest Group. Validation of the Sicca Symptoms Inventory for clinical studies of Sjögren's syndrome. J Rheumatol 2003; 30: 125966.